On May 19, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced plans for an international Phase 3 trial of OCA in patients with NASH. Although this …
Wedbush analyst Liana Moussatos weighed in today with a few insights on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the company announced the design of its …
Recently, various executives have taken part in insider selling activity for the stocks of Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Pandora Media Inc (NYSE:P), Tesla Motors …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced its plans for an international Phase 3 trial of obeticholic acid (OCA), the company’s lead FXR agonist, in patients …
On May 11, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported first quarter earnings for 2015. The biopharmaceutical company does not yet have any approved products …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat neglected chronic liver …
In a research note issued today, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) with a $493 price …
On April 6, analysts at Wedbush led by Liana Moussatos highlighted upcoming events in the biotech sector. Here is what to watch for: OvaScience Inc …
Intercept Pharmaceuticals Inc (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat neglected chronic liver diseases, …
Recently, various executives have taken part in insider selling activity for the stocks of QUALCOMM, Inc. (NASDAQ:QCOM), Pandora Media Inc (NYSE:P), Ariad Pharmaceuticals, …
